SE8500339L - Berarbundet histamin, dess framstellning och anvendning - Google Patents

Berarbundet histamin, dess framstellning och anvendning

Info

Publication number
SE8500339L
SE8500339L SE8500339A SE8500339A SE8500339L SE 8500339 L SE8500339 L SE 8500339L SE 8500339 A SE8500339 A SE 8500339A SE 8500339 A SE8500339 A SE 8500339A SE 8500339 L SE8500339 L SE 8500339L
Authority
SE
Sweden
Prior art keywords
histamine
carrier
hydrogen
derivative
bound
Prior art date
Application number
SE8500339A
Other languages
Unknown language ( )
English (en)
Other versions
SE8500339D0 (sv
Inventor
E Akerblom
A Norrman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8500339A priority Critical patent/SE8500339L/sv
Publication of SE8500339D0 publication Critical patent/SE8500339D0/sv
Priority to ES551220A priority patent/ES8702369A1/es
Priority to PCT/SE1986/000027 priority patent/WO1986004331A1/en
Priority to AU53963/86A priority patent/AU5396386A/en
Priority to JP61500909A priority patent/JPS62501560A/ja
Priority to EP86901155A priority patent/EP0208776A1/en
Publication of SE8500339L publication Critical patent/SE8500339L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8500339A 1985-01-24 1985-01-24 Berarbundet histamin, dess framstellning och anvendning SE8500339L (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8500339A SE8500339L (sv) 1985-01-24 1985-01-24 Berarbundet histamin, dess framstellning och anvendning
ES551220A ES8702369A1 (es) 1985-01-24 1986-01-24 Procedimiento para ligar histamina a un soporte
PCT/SE1986/000027 WO1986004331A1 (en) 1985-01-24 1986-01-24 Carrier-bound histamine, its manufacture and its use
AU53963/86A AU5396386A (en) 1985-01-24 1986-01-24 Carrier-bound histamine, its manufacture and its use
JP61500909A JPS62501560A (ja) 1985-01-24 1986-01-24 担体結合ヒスタミン、その製法及び使用
EP86901155A EP0208776A1 (en) 1985-01-24 1986-01-24 Carrier-bound histamine, its manufacture and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8500339A SE8500339L (sv) 1985-01-24 1985-01-24 Berarbundet histamin, dess framstellning och anvendning

Publications (2)

Publication Number Publication Date
SE8500339D0 SE8500339D0 (sv) 1985-01-24
SE8500339L true SE8500339L (sv) 1986-07-25

Family

ID=20358885

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8500339A SE8500339L (sv) 1985-01-24 1985-01-24 Berarbundet histamin, dess framstellning och anvendning

Country Status (6)

Country Link
EP (1) EP0208776A1 (sv)
JP (1) JPS62501560A (sv)
AU (1) AU5396386A (sv)
ES (1) ES8702369A1 (sv)
SE (1) SE8500339L (sv)
WO (1) WO1986004331A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
DE4025726A1 (de) * 1990-08-14 1992-02-20 Boehringer Mannheim Gmbh Bestimmung von biogenen aminen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2301532A (en) * 1938-08-18 1942-11-10 Parke Davis & Co Biological product and process of obtaining same
US2372066A (en) * 1940-12-23 1945-03-20 Parke Davis & Co Biological product and process of obtaining same
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
GB1316990A (en) * 1970-09-17 1973-05-16 Roche Products Ltd Imidazolyl derivatives
US3873697A (en) * 1972-11-11 1975-03-25 Mack Chem Pharm Histamine antigen
US4016146A (en) * 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
DE3322117A1 (de) * 1983-06-20 1984-12-20 Diamalt AG, 8000 München Verfahren zur herstellung von n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivaten, n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivate und ihre verwendung

Also Published As

Publication number Publication date
JPS62501560A (ja) 1987-06-25
WO1986004331A1 (en) 1986-07-31
EP0208776A1 (en) 1987-01-21
ES551220A0 (es) 1986-12-16
AU5396386A (en) 1986-08-13
SE8500339D0 (sv) 1985-01-24
ES8702369A1 (es) 1986-12-16

Similar Documents

Publication Publication Date Title
CA2122627A1 (en) Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
SE431877B (sv) Sampolymer av en aminimid och en halometylgrupphaltig vinylforening for anvending vid affinitetskromatografi
EP0319957A3 (en) A method for modifying the surface of a polymer
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
ATE130197T1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
DE69121844D1 (de) Immunotest für Cyclosporin
GB1597754A (en) Reagent for use in immunochemical assay methods
AU585253B2 (en) Carrier material for use in immune determinations
ATE110110T1 (de) Verfahren zum immobilisieren von proteinen, peptiden, coenzymen od.dgl. an einem träger.
ATE216593T1 (de) Modulation der immunantwort
EP0194578A3 (en) Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials
ATE72831T1 (de) Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung.
GB2033917B (en) Carrier bonded disulphide compounds
SE8500339D0 (sv) Berarbundet histamin, dess framstellning och anvendning
EP0270930A3 (en) Substantially pure enzyme-antibody conjugate preparations
ATE90790T1 (de) Verfahren zur herstellung einer festphasenmatrix.
JPS55136261A (en) Novel compound and kit comprising it
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
Jackson et al. Binding of mitochondrial ATPase from ox heart to its naturally occurring inhibitor protein: Localization by antibody binding
DE69014300D1 (de) Radioaktive markierung von proteinen.
DE69221826D1 (de) Aufgetragene Mikrokugeln
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
PT89290A (pt) Processo para a preparacao de derivados de 9-oxa(ou tia)-3,4-diaza-fenantreno(ou fluoreno), agonistas dos receptores colinergicos
FI861321A0 (fi) Foerfaranden foer stabilisering av prostatspecifik antigen i naturella matriser.
FI903504A0 (fi) Foerfarande foer bestaemning av antigener och/eller antikroppar i maenniskans kroppsvaetskor samt provset foer genomfoerande av foerfarandet.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8500339-0

Effective date: 19880328